Deep Brain Stimulation (DBS): Installing a “Precision Regulator” for the Brain — Giving “Frozen‑in‑Time” Patients a Chance to Take Steps Again
Uncontrollable trembling of hands and feet; once‑simple movements such as standing up and stepping forward become extremely difficult, as if the body is locked by invisible shackles. This is the daily reality for many patients living with Parkinson’s disease and other movement disorders. When medications gradually lose efficacy and side‑effects worsen, patients and their families often feel helpless: apart from increasing drug dosages, are there any other options? Deep Brain Stimulation (DBS) offers a new solution.
This article systematically introduces: What exactly is DBS? Which conditions can it treat? How is the surgery performed? And what full‑cycle clinical services are available for patients at Beijing Boren Hospital.
I. What is DBS?
Deep Brain Stimulation (DBS), commonly known as a “brain pacemaker” therapy. A hair‑thin electrode is implanted into a specific brain region and connected to a pulse generator placed subcutaneously beneath the chest. It delivers faint electrical pulses to modulate abnormal neural circuits inside the brain.
Analogy: If brain neural signals act like a malfunctioning electrical circuit, DBS precisely “resets” or “tunes” this faulty circuit. It does not remove brain tissue, nor is it electroshock therapy. The whole procedure is minimally‑invasive and reversible, and stimulation parameters can be adjusted anytime according to each patient’s condition.
With over 30 years of clinical application, DBS represents a mature neuromodulation technique.
II. Which Diseases Can DBS Treat?
DBS was initially developed for movement‑disorder conditions such as Parkinson’s disease. As technology advances, its indications keep expanding into two major categories:
1. Movement Disorders
Parkinson’s disease: The primary patient population for DBS. For patients with poorly‑controlled or progressively worsening symptoms despite medication, DBS significantly improves core manifestations including limb tremor, rigidity and bradykinesia.
Essential tremor: A common movement disorder featured by postural or kinetic tremor predominantly affecting distal upper extremities; it may also involve the head and voice, without dystonia or other parkinson‑like neurological signs.
Dystonia: Including torsion spasm, spasmodic torticollis, Meige’s syndrome (facial dystonia), and others.
2. Psychiatric Disorders
Treatment‑resistant obsessive‑compulsive disorder
Treatment‑resistant depression
For Parkinson’s patients, DBS has reshaped conventional treatment paradigms. Its overall clinical benefits are well‑validated, making it a key therapeutic alternative when drug efficacy fades or severe drug‑related adverse events emerge.
III. How Does DBS Work?
The DBS system consists of three core components:
Intracranial stimulating electrode: Micro‑electrode implanted into designated deep‑brain nuclei.
Subcutaneous extension lead: Connects the brain electrode to the pulse generator.
Pulse generator: Implanted “battery‑controller” placed subcutaneously below the clavicle in the chest wall.
During surgery, stereotactic techniques combined with image guidance allow surgeons to implant electrodes precisely into deep‑brain target nuclei. After device activation, the pulse generator sends electrical signals via electrodes to stimulate target nuclei and modulate aberrant neural activity.
Rather than directly repairing damaged nerve cells, electrical stimulation relieves symptoms by reshaping neural‑circuit function. Its key strengths include adjustability, reversibility and minimal tissue trauma.
IV. DBS Treatment at Beijing Boren Hospital
Beijing Boren Hospital hosts the Parkinson’s Disease and Movement Disorder Center, which adopts a joint neurology‑neurosurgery multidisciplinary model. It delivers one‑stop full‑cycle services: standardized pre‑surgical assessment, intra‑operative electrophysiological monitoring, precise post‑operative programming, and complete rehabilitation management.
Supported by this platform, the hospital has achieved multiple clinical breakthroughs in DBS, including several national‑pioneer and national‑first‑in‑series innovations:
New‑generation G108R Brain Pacemaker As one of China’s earliest‑adopting centres, the hospital has completed implantations of the new‑generation G108R brain pacemaker. Compared with prior models, this device is 43 % smaller in volume, 24 % thinner and 35 % lighter. Its anatomical profile better matches Asian brain anatomy, catering to individualized management for complex and challenging cases. It supports real‑time EEG recording, motor‑ and sleep‑data monitoring, and contains hardware readiness for future closed‑loop stimulation upgrades. The two operated patients are expected to gain substantial relief from motor and non‑motor symptoms and regain independence in daily living.
State‑of‑the‑art Smart Brain Pacemaker and Directional Leads Keeping pace with global frontiers, the hospital performed some of China’s first implantations of the Medtronic Percept™ RC brain pacemaker paired with SenSight™ directional leads. This system ranks among the world’s most advanced neuromodulation platforms: it captures real‑time brain‑wave data, monitors movement and sleep metrics, and is hardware‑ready for closed‑loop stimulation. Directional leads focus electrical energy selectively on target nuclei, minimising unwanted stimulation of adjacent non‑target brain tissue and lowering side‑effect risks. The recipient, a 50‑year‑old patient with mid‑to‑late‑stage Parkinson’s disease, obtained marked symptom relief and improved mobility post‑operatively.
Four‑Contact Directional‑Lead DBS The hospital has carried out dual‑target DBS with Boston Scientific Vercise Genus™ four‑channel directional leads. This electrode enables concurrent stimulation of the pallidothalamic tract (PTT) and subthalamic nucleus (STN). Independent tuning of amplitude and direction for each channel enables highly personalised parameter programming and helps reduce known DBS‑related adverse effects such as speech impairment and cognitive decline. The 68‑year‑old female patient recovered well after surgery; bradykinesia and rigidity of her left limbs improved greatly with no notable complications.
Dual‑Target Precise Stimulation Conventional single‑target DBS yields limited improvement for symptoms such as gait freezing. Beijing Boren Hospital completed China’s first STN + SNr dual‑target DBS procedure, stimulating both the subthalamic nucleus (STN) and substantia nigra pars reticulata (SNr) to treat gait freezing. After surgery, 65‑year‑old patient Ms. Guo experienced obvious improvement in limb tremor and freezing‑of‑gait. She escaped the sensation of feet being glued to the ground and no longer lived in constant fear of falling.
V. DBS Surgical Workflow and Important Considerations
DBS surgery is generally performed in two stages:
Step 1: Electrode implantation. Under general anaesthesia, small cranial incisions are made. Guided by high‑precision imaging, micro‑electrodes are positioned in target brain regions, with intra‑operative electrophysiology to confirm accurate placement.
Step 2: Pulse‑generator implantation. The pulse generator is placed under chest skin and connected via extension leads to intracranial electrodes.
Approximately 2‑4 weeks after surgery, patients attend device activation and programming sessions. External programming tools adjust stimulation parameters to establish an optimised individual therapeutic profile.
DBS is not suitable for every patient. Rigorous pre‑operative evaluation is mandatory, including motor‑symptom assessment, non‑motor‑symptom profiling, neuro‑psychological testing and neuroimaging, to confirm diagnosis and surgical eligibility. Regular follow‑up visits and parameter adjustments are required after discharge; DBS management represents a long‑term clinical process.
Conclusion
Deep Brain Stimulation (DBS) is a landmark technology within neuromodulation. For patients with Parkinson’s disease, essential tremor and other movement disorders whose response to medication has waned, DBS opens new therapeutic possibilities.
The Parkinson’s Disease and Movement Disorder Center at Beijing Boren Hospital continues advancing real‑world clinical practice. Drawing on multidisciplinary collaboration, next‑generation hardware, and full‑cycle patient pathways, it delivers comprehensive care. As one patient commented post‑operatively: “This day marks my new birthday.”
If you or your family members suffer from Parkinson’s disease or other movement disorders with insufficient drug control, please consult specialists to learn more about DBS as a potential treatment option.
Comments